Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene expression patterns in ovarian carcinomas.

Marci E Schaner1, Douglas T Ross, Giuseppe Ciaravino

  • 1Stanford University School of Medicine, Stanford, California 94305-5151, USA.

Molecular Biology of the Cell
|September 10, 2003
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial Expression of Concern: Decreased levels of baseline and drug-induced tubulin polymerisation are hallmarks of resistance to taxanes in ovarian cancer cells and are associated with epithelial-to-mesenchymal transition.

British journal of cancer·2025
Same author

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Nature communications·2025
Same author

An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer.

Molecular oncology·2024
Same author

Continuous 72-h infusion of zosuquidar with chemotherapy in patients with newly diagnosed acute myeloid leukemia stratified for leukemic blast P-glycoprotein phenotype.

Cancer chemotherapy and pharmacology·2024
Same author

Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer.

Cellular and molecular life sciences : CMLS·2023
Same author

A clinical trial of zosuquidar plus gemtuzumab ozogamicin (GO) in relapsed or refractory acute myeloid leukemia (RR AML): evidence of efficacy based on leukemic blast P-glycoprotein functional phenotype.

Cancer chemotherapy and pharmacology·2023
Same journal

Mechanisms underpinning chromosome structure in metazoans.

Molecular biology of the cell·2026
Same journal

Conserved and Divergent Modes of Substrate Interaction Define Selective Localizations and Functions of a Cdc14 Phosphatase.

Molecular biology of the cell·2026
Same journal

Dimerization of the centriolin-like protein Nud1 governs spindle pole body inheritance in budding yeast.

Molecular biology of the cell·2026
Same journal

Non-muscle Myosin II acts as a negative feedback mediator to control cell contraction dynamics in adherent cells.

Molecular biology of the cell·2026
Same journal

The tetraspanin disc proteins, peripherin-2 and ROM1, facilitate CNG channel localization to the rod outer segment.

Molecular biology of the cell·2026
Same journal

Csf1 facilitates adaptive membrane lipid remodeling linked to ER-plasma membrane contact sites.

Molecular biology of the cell·2026
See all related articles
This summary is machine-generated.

This study used DNA microarrays to analyze gene expression in ovarian cancers. Researchers identified distinct gene patterns for clear cell subtypes and differentiated ovarian from breast cancers, aiding in diagnosis and treatment insights.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Ovarian cancer subtypes exhibit varying prognoses and treatment responses.
  • Understanding gene expression differences is crucial for accurate diagnosis and targeted therapies.

Purpose of the Study:

  • To characterize global gene expression patterns in ovarian epithelial cancers.
  • To identify gene expression signatures distinguishing ovarian cancer subtypes and differentiating them from breast cancer.

Main Methods:

  • DNA microarrays were employed to analyze gene expression profiles.
  • Gene expression data from ovarian and breast cancer specimens were compared.

Main Results:

  • Distinct gene expression patterns differentiated clear cell ovarian carcinomas from other subtypes.

Related Experiment Videos

  • A panel of 62 genes accurately classified 125 breast and ovarian cancer specimens.
  • Genes such as PAX8, mesothelin, and ephrin-B1 were highly expressed in ovarian carcinomas.
  • Estrogen receptor co-expression patterns differed between ovarian and breast cancers.

    • Conclusions:

    • Gene expression profiling can distinguish ovarian cancer subtypes and primary sites.
    • Identified gene signatures may offer insights into clear cell carcinoma's prognosis and resistance.
    • Differential gene expression provides a basis for improved diagnostic and therapeutic strategies in ovarian and breast cancers.